Aura Biosciences, Inc.
AURANasdaqCIK 1501796HealthcareFiscal year ends Dec 31
Reports and events: 89 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2023-11-0616:01 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-271351 |
| 2023-10-0216:11 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-23-249055 |
| 2023-08-0907:10 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000950170-23-040138 |
| 2023-08-0907:05 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-23-040136 |
| 2023-06-0716:52 ET | 8-K | 5.07 Shareholder vote results | 0001193125-23-162617 |
| 2023-05-1116:27 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0000950170-23-021302 |
| 2023-05-1116:20 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-23-021284 |
| 2023-04-2516:05 ET | DEF 14A | Proxy statementPeriod 2023-06-07 | 0001193125-23-115288 |
| 2023-04-0407:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-23-090316 |
| 2023-03-1516:27 ET | 10-K | Annual reportPeriod 2022-12-31 | 0000950170-23-008166 |
| 2023-03-1516:25 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-008163 |
| 2023-02-1608:13 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-040742 |
| 2023-01-0617:23 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-003670 |
| 2022-12-0716:30 ET | SC 13D/A | Ownership report, active investor, amended | 0000902664-22-005060 |
| 2022-12-0517:12 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-22-298535 |
| 2022-11-3016:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-295368 |
| 2022-11-1007:11 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0000950170-22-024150 |
| 2022-11-1007:05 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-22-024145 |
| 2022-10-0307:05 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-256110 |
| 2022-09-2808:43 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-22-252714 |
| 2022-08-1116:29 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0000950170-22-016911 |
| 2022-08-1116:25 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-22-016905 |
| 2022-06-3007:31 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-22-185580 |
| 2022-06-2217:02 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-22-178857 |
| 2022-06-1517:02 ET | 8-K | 5.07 Shareholder vote results | 0001193125-22-174863 |
| 2022-05-2718:04 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-22-161235 |
| 2022-05-1816:06 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001193125-22-154031 |
| 2022-05-1216:33 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0000950170-22-009719 |
| 2022-05-1216:29 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-22-009706 |
| 2022-04-2816:17 ET | DEF 14A | Proxy statementPeriod 2022-06-15 | 0001193125-22-127614 |
| 2022-03-2316:26 ET | 10-K | Annual reportPeriod 2021-12-31 | 0000950170-22-004425 |
| 2022-03-2316:21 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-22-004419 |
| 2021-11-2416:21 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0000950170-21-004908 |
| 2021-11-2416:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-21-004906 |
| 2021-11-1015:21 ET | SC 13D | Ownership report, active investor | 0001193125-21-325850 |
| 2021-11-0416:58 ET | SC 13D | Ownership report, active investor | 0000902664-21-004741 |
| 2021-11-0216:06 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-21-316929 |
| 2021-10-2506:06 ET | S-1/A | Registration statement, amended | 0001193125-21-305934 |
| 2021-10-0816:38 ET | S-1 | Registration statement | 0001193125-21-295543 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 18:49 ET. Listed shows no prices and gives no investment advice.